
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

5 days ago
5 days ago
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES
Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.
The experts
- Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada
- Prof. Dr. med. Oliver Cornely – University of Cologne, Germany
- Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Moderna. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchinfectiousdiseasesime.org/mrna-vaccine-platform-respiratory-viral-infections

5 days ago
5 days ago
touchEXPERT OPINIONS for touchRESPIRATORY
Listen to three leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.
The experts
- Dr Anna Blakney – University of British Columbia, Vancouver, BC, Canada
- Prof. Dr. med. Oliver Cornely – University of Cologne, Germany
- Prof. Ann R Falsey – University of Rochester School of Medicine, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Moderna. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mrna-vaccine-platform-respiratory-viral-infections/

Thursday Sep 14, 2023
Thursday Sep 14, 2023
touchIN CONVERSATION for touchRESPIRATORY
Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations.
In Part 1 they respond to questions from the oncology and respiratory clinical communities on:
- Biomarker testing in advanced NSCLC
- Identifying patients with METex14 skipping mutations
- Targeting METex14 skipping mutations
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the healthcare Business of Merck KGaA, Darmstadt, Germany, and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/met-alterations-nsclc-management/

Thursday Sep 14, 2023
Thursday Sep 14, 2023
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations.
In Part 1 they respond to questions from the oncology and respiratory clinical communities on:
- Biomarker testing in advanced NSCLC
- Identifying patients with METex14 skipping mutations
- Targeting METex14 skipping mutations
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from the healthcare Business of Merck KGaA, Darmstadt, Germany, and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/met-alterations-nsclc-management/

Thursday Sep 14, 2023
Optimizing androgen deprivation therapy (ADT) in advanced prostate cancer
Thursday Sep 14, 2023
Thursday Sep 14, 2023
touchEXPERT OPINIONS for touchONCOLOGY
An oncologist, a nurse and a urologist share their insights on the risks and benefits of androgen deprivation therapy, the barriers to equitable care and how to improve treatment adherence for patients with prostate cancer.
The experts
- Dr Tanya Dorff, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
- Ms Brenda Martone, Northwestern Medicine, Chicago, IL, USA
- Dr Stephen Freedland, Cedars-Sinai, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Pfizer Inc. and is jointly provided by USF Health and touchIME.
For further information visit: touchoncology.com

Monday Sep 11, 2023
Optimizing IOL selection Focus on IOL calculations in “difficult” eyes
Monday Sep 11, 2023
Monday Sep 11, 2023
touchIN CONVERSATION for touchOPHTHALMOLOGY
In this activity, listen to ophthalmology experts, Prof. Sumit Garg and Dr Karolinne Rocha, respond to questions from the ophthalmology community on IOL selection in cataract patients, focusing on the preoperative assessment of ocular health, optimizing IOL calculations, and the impact of previous surgeries on lens selection.
This touchPODCAST is for healthcare professionals only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: touchOPHTHALMOLOGY

Wednesday Aug 30, 2023
Anti-CGRP antibody preventive treatment of migraine: Practical management
Wednesday Aug 30, 2023
Wednesday Aug 30, 2023
touchCLINICAL PERSPECTIVES for touchNEUROLOGY
Listen to two case-based interviews with migraine specialists focusing on preventive treatment of migraine with anti-CGRP antibodies. In the first, a clinical expert shares his perspectives on treatment failure in patients with migraine, providing insights and guidance, while the second discussion considers different clinical scenarios to focus on practical management.
The experts:
- Prof. Christian Lampl, Konventhospital Barmherzige Brüder, Linz, Austria
- Dr Simy Parikh, Thomas Jefferson University Hospital, Philadelphia, PA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an educational grant from Eli Lilly and Company Limited. This medical education is provided by touchIME.
For further information visit our website:
https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/

Tuesday Aug 15, 2023
The complement system in NMOSD and MG: A target for therapeutic benefit?
Tuesday Aug 15, 2023
Tuesday Aug 15, 2023
touchPANEL DISCUSSION for touchOPHTHALMOLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
- Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
- Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
To view this activity in full and to access the downloadable materials please visit: touchOPHTHALMOLOGY

Tuesday Aug 15, 2023
The complement system in NMOSD and MG: A target for therapeutic benefit?
Tuesday Aug 15, 2023
Tuesday Aug 15, 2023
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
- Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
- Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA
This touchPODCAST is for HCPs only.
An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchIMMUNOLOGY

Tuesday Aug 15, 2023
The complement system in NMOSD and MG: A target for therapeutic benefit
Tuesday Aug 15, 2023
Tuesday Aug 15, 2023
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
- Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
- Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA
This touchPODCAST is for HCPs only.
An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchNEUROLOGY